{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T02:30:47Z","timestamp":1787020247249,"version":"build-2736575974"},"reference-count":19,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,4,8]],"date-time":"2024-04-08T00:00:00Z","timestamp":1712534400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2024,4,8]],"date-time":"2024-04-08T00:00:00Z","timestamp":1712534400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"The Medical Health Science and Technology Project of Zhejiang Province","award":["2022KY618"],"award-info":[{"award-number":["2022KY618"]}]},{"name":"The Medical Health Science and Technology Project of Zhejiang Province","award":["2023KY610"],"award-info":[{"award-number":["2023KY610"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Cancer"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Prophylactic cranial irradiation (PCI) is part of standard care in limited-stage small cell lung cancer (SCLC) at present. As evidence from retrospective studies increases, the benefits of PCI for limited-stage SCLC are being challenged.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>A multicenter, prospective, randomized controlled study was designed. The key inclusion criteria were: histologically or cytologically confirmed small cell carcinoma, age\u2009\u2265\u200918 years, KPS\u2009\u2265\u200980, limited-stage is defined as tumor confined to one side of the chest including ipsilateral hilar, bilateral mediastinum and supraclavicular lymph nodes, patients have received definitive thoracic radiotherapy (regardless of the dose-fractionation of radiotherapy used) and chemotherapy, evaluated as complete remission (CR) of tumor 4\u20136 weeks after the completion of chemo-radiotherapy. Eligible patients will be randomly assigned to two arms: (1) PCI and brain MRI surveillance arm, receiving PCI (2.5\u00a0Gy qd to a total dose of 25\u00a0Gy in two weeks) followed by brain MRI surveillance once every three months for two years; (2) brain MRI surveillance alone arm, undergoing brain MRI surveillance once every three months for two years. The primary objective is to compare the 2-year brain metastasis-free survival (BMFS) rates between the two arms. Secondary objectives include 2-year overall survival (OS) rates, intra-cranial failure patterns, 2-year progression-free survival rates and neurotoxicity. In case of brain metastasis (BM) detect during follow-up, stereotactic radiosurgery (SRS) will be recommended if patients meet the eligibility criteria.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Discussion<\/jats:title>\n                    <jats:p>Based on our post-hoc analysis of a prospective study, we hypothesize that in limited-stage SCLC patients with CR after definitive chemoradiotherapy, and ruling out of BM by MRI, it would be feasible to use brain MRI surveillance and omit PCI in these patients. If BM is detected during follow-up, treatment with SRS or whole brain radiotherapy does not appear to have a detrimental effect on OS. Additionally, this approach may reduce potential neurotoxicity associated with PCI.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12885-024-12123-x","type":"journal-article","created":{"date-parts":[[2024,4,8]],"date-time":"2024-04-08T07:02:02Z","timestamp":1712559722000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Rational and design of prophylactic cranial irradiation (PCI) and brain MRI surveillance versus brain MRI surveillance alone in patients with limited-stage small cell lung cancer achieving complete remission (CR) of tumor after chemoradiotherapy: a multicenter prospective randomized study"],"prefix":"10.1186","volume":"24","author":[{"given":"Mengyuan","family":"Chen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Runhua","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yue","family":"Kong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lei","family":"Shi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuezhen","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yujin","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yongling","family":"Ji","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiao","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,4,8]]},"reference":[{"issue":"28","key":"12123_CR1","doi-asserted-by":"publisher","first-page":"4539","DOI":"10.1200\/JCO.2005.04.4859","volume":"24","author":"R Govindan","year":"2006","unstructured":"Govindan R, Page N, Morgensztern D, William R, Ryan T, Anna V, et al. Changing epidemiology of small-cell lung cancer in the United States over the last 30 years: analysis of the surveillance, epidemiologic, and end results database. J Clin Oncol. 2006;24(28):4539\u201344.","journal-title":"J Clin Oncol"},{"key":"12123_CR2","unstructured":"https:\/\/www.nccn.org\/professionals\/physician_gls\/pdf\/sclc.pdf."},{"key":"12123_CR3","doi-asserted-by":"publisher","first-page":"476","DOI":"10.1056\/NEJM199908123410703","volume":"341","author":"A Aup\u00e9rin","year":"1999","unstructured":"Aup\u00e9rin A, Arriagada R, Pignon JP, Le PC, Gregor A, Stephenset RJ. Prophylactic cranial irradiation for patients with small cell lung cancer in complete remission. N Engl J Med. 1999;341:476\u201384.","journal-title":"N Engl J Med"},{"issue":"8","key":"12123_CR4","first-page":"608","volume":"29","author":"Clinical practice guideline for","year":"2020","unstructured":"Clinical practice guideline for. Radiation therapy in small cell lung cancer (2020 version) Chinese Journal of Radiation Oncology|. Chin J Radiat Oncol. 2020;29(8):608\u201314.","journal-title":"Chin J Radiat Oncol"},{"issue":"8","key":"12123_CR5","doi-asserted-by":"publisher","first-page":"1827","DOI":"10.1002\/cncr.23361","volume":"112","author":"T Seute","year":"2008","unstructured":"Seute T, Leffers P, ten Velde GP, Twijnstra A. Detection of brain metastases from small cell lung cancer: consequences of changing imaging techniques (CT versus MRI). Cancer. 2008;112(8):1827\u201334.","journal-title":"Cancer"},{"key":"12123_CR6","doi-asserted-by":"publisher","first-page":"1118371","DOI":"10.3389\/fonc.2023.1118371","volume":"13","author":"Q Wu","year":"2023","unstructured":"Wu Q, Chen M, Peng F, et al. A study of the prognosis of patients with limited-stage small cell lung cancer who did or did not receive prophylactic cranial irradiation after effective chemoradiotherapy. Front Oncol. 2023;13:1118371.","journal-title":"Front Oncol"},{"issue":"4","key":"12123_CR7","doi-asserted-by":"publisher","first-page":"840","DOI":"10.1002\/cncr.32586","volume":"126","author":"X Hu","year":"2020","unstructured":"Hu X, Bao Y, Xu YJ, Zhu H, Chen M, et al. Final report of a prospective randomized study on thoracic radiotherapy target volume for limited-stage small cell lung cancer with radiation dosimetric analyses. Cancer. 2020;126(4):840\u20139.","journal-title":"Cancer"},{"issue":"3","key":"12123_CR8","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1093\/jnci\/87.3.183","volume":"87","author":"R Arriagada","year":"1995","unstructured":"Arriagada R, Le Chevalier T, Borie F, Santos-Miranda JA, Bardec E, Laplanche A, et al. Prophylactic cranial irradiation for patients with small\u2013cell lung cancer in complete remission. J Natl Cancer Inst. 1995;87(3):183\u201390.","journal-title":"J Natl Cancer Inst"},{"issue":"7","key":"12123_CR9","doi-asserted-by":"publisher","first-page":"664","DOI":"10.1056\/NEJMoa071780","volume":"357","author":"B Slotman","year":"2007","unstructured":"Slotman B, Faivre-Finn C, Kramer G, Rankin E, Snee M, Hatton M, et al. Prophylactic cranial irradiation in extensive small-cell lung cancer. N Engl J Med. 2007;357(7):664\u201372.","journal-title":"N Engl J Med"},{"issue":"5","key":"12123_CR10","doi-asserted-by":"publisher","first-page":"663","DOI":"10.1016\/S1470-2045(17)30230-9","volume":"18","author":"T Takahashi","year":"2017","unstructured":"Takahashi T, Yamanaka T, Seto T, Nokihara H, Saka H, Nishio M, Kaneda H, et al. Prophylactic cranial irradiation versus observation in patients with extensive-disease small-cell lung cancer: a multicentre, randomised, open-label, phase 3 trial. Lancet Oncol. 2017;18(5):663\u201371.","journal-title":"Lancet Oncol"},{"issue":"7","key":"12123_CR11","doi-asserted-by":"publisher","first-page":"1028","DOI":"10.1001\/jamaoncol.2020.1271","volume":"6","author":"CG Rusthoven","year":"2020","unstructured":"Rusthoven CG, Yamamoto M, Bernhardt D, Smith DE, Robin TP. Evaluation of first-line radiosurgery vs whole-brain radiotherapy for small cell lung cancer brain metastases: the FIRE-SCLC Cohort Study. JAMA Oncol. 2020;6(7):1028\u201337.","journal-title":"JAMA Oncol"},{"key":"12123_CR12","doi-asserted-by":"publisher","first-page":"589","DOI":"10.1186\/s12885-015-1593-2","volume":"15","author":"Y Ozawa","year":"2015","unstructured":"Ozawa Y, Omae M, Fujii M, Takashi M, Masato K, Shinyaet S, et al. Management of brain metastasis with magnetic resonance imaging and stereotactic irradiation attenuated benefits of prophylactic cranial irradiation in patients with limited-stage small cell lung cancer. BMC Cancer. 2015;15:15:589.","journal-title":"BMC Cancer"},{"issue":"4","key":"12123_CR13","doi-asserted-by":"publisher","first-page":"e201929","DOI":"10.1001\/jamanetworkopen.2020.1929","volume":"3","author":"TA Pezzi","year":"2020","unstructured":"Pezzi TA, Fang P, Gjyshi O, Feng L, Liu S, Komaki R, et al. Rates of overall survival and Intracranial Control in the magnetic resonance imaging era for patients with Limited-Stage Small Cell Lung Cancer with and without prophylactic cranial irradiation. JAMA Netw Open. 2020;3(4):e201929.","journal-title":"JAMA Netw Open"},{"key":"12123_CR14","doi-asserted-by":"publisher","first-page":"833478","DOI":"10.3389\/fonc.2022.833478","volume":"12","author":"C Qi","year":"2022","unstructured":"Qi C, Li W, Li H, Patel A, Beriwal S, et al. Benefits of prophylactic cranial irradiation in the MRI era for patients with Limited Stage Small Cell Lung Cancer. Front Oncol. 2022;12:833478.","journal-title":"Front Oncol"},{"issue":"4","key":"12123_CR15","doi-asserted-by":"publisher","first-page":"656","DOI":"10.1016\/j.ijrobp.2013.02.033","volume":"86","author":"V Gondi","year":"2013","unstructured":"Gondi V, Paulus R, Bruner DW, Christina A, Elizabeth M, Aaron W, et al. Decline in tested and self-reported cognitive functioning after prophylactic cranial irradiation for lung cancer: pooled secondary analysis of Radiation Therapy Oncology Group randomized trials 0212 and 0214. Int J Radiat Oncol Biol Phys. 2013;86(4):656\u201364.","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"4","key":"12123_CR16","doi-asserted-by":"publisher","first-page":"548","DOI":"10.1016\/j.adro.2017.08.001","volume":"2","author":"BH Lok","year":"2017","unstructured":"Lok BH, Ma J, Foster A, Perez A, Abraham J. Factors influencing the utilization of prophylactic cranial irradiation in patients with limited-stage small cell lung cancer. Adv Radiat Oncol. 2017;2(4):548\u201354.","journal-title":"Adv Radiat Oncol"},{"key":"12123_CR17","unstructured":"SWOG S1827 (MAVERICK). Testing whether the use of brain scans alone instead of brain scans plus preventive brain radiation affects lifespan in patients with small cell lung cancer. https:\/\/clinicaltrials.gov\/ct2\/show\/NCT04155034."},{"key":"12123_CR18","unstructured":"PRophylactic Cerebral Irradiation or Active MAgnetic. Resonance imaging surveillance in small-cell lung Cancer patients (PRIMALung Study). https:\/\/clinicaltrials.gov\/study\/NCT04790253?cond=NCT04790253&rank=1"},{"key":"12123_CR19","unstructured":"Efficacy and Safety of Prophylactic Cranial Irradiation Versus MRI Surveillance in Patients. With limited-stage small cell Lung Cancer who Achieved Remission after First-line Chemoradiotherapy: a Multicenter Randomized Controlled Phase III Clinical Trial. https:\/\/clinicaltrials.gov\/study\/NCT04829708?cond=NCT04829708&rank=1"}],"container-title":["BMC Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12885-024-12123-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12885-024-12123-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12885-024-12123-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,4,8]],"date-time":"2024-04-08T07:02:30Z","timestamp":1712559750000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmccancer.biomedcentral.com\/articles\/10.1186\/s12885-024-12123-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,4,8]]},"references-count":19,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["12123"],"URL":"https:\/\/doi.org\/10.1186\/s12885-024-12123-x","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-3330197\/v1","asserted-by":"object"}]},"ISSN":["1471-2407"],"issn-type":[{"value":"1471-2407","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,4,8]]},"assertion":[{"value":"6 September 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 March 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 April 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All experimental protocols were approved by the Medical Ethics Committee of Zhejiang Cancer Hospital(The Ethics is IRB-2022-758, the work will be obtained from all subjects and\/or their legal guardian(s). The corresponding author has read the journal policies and submit this manuscript in accordance with those policies, we confirmed that informed consent will be obtained from all subjects and\/or their legal guardian(s).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to publication"}},{"value":"The authors have no competing interests as defined by BMC, or other interests that might be perceived to influence the results and\/or discussion reported in this paper. The manuscript had not been published elsewhere, nor are they under consideration by another publisher.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}],"article-number":"429"}}